| |
U133 probe set |
Gene description |
Symbol |
Location |
GenBank reference |
UniGene reference |
SAM d-score |
CBF Above/ Below mean |
Fold change |
| 1 |
206187_at |
prostaglandin I2 (prostacyclin)
receptor (IP) |
PTGIR |
Chr:19q13.3 |
NM_000960 |
Hs.458324 |
11.2 |
Above |
4.3 |
| 2 |
205529_s_at |
core-binding factor, runt domain,
alpha subunit 2; translocated to, 1; cyclin
D-related |
CBFA2T1 |
Chr:8q22 |
NM_004349 |
Hs.90858 |
10.3 |
Above |
13.7 |
| 3 |
205528_s_at |
core-binding factor, runt domain,
alpha subunit 2; translocated to, 1; cyclin
D-related |
CBFA2T1 |
Chr:8q22 |
X79990 |
Hs.90858 |
9.9 |
Above |
19.6 |
| 4 |
206622_at |
thyrotropin-releasing hormone |
TRH |
Chr:3q13.3-q21 |
NM_007117 |
Hs.182231 |
9.7 |
Above |
14.4 |
| 5 |
204495_s_at |
DKFZP434H132 protein |
DKFZP434H132 |
Chr:15q23 |
NM_015492 |
Hs.17936 |
-9.6 |
Below |
2.3 |
| 6 |
204494_s_at |
DKFZP434H132 protein |
DKFZP434H132 |
Chr:15q23 |
AW516789 |
Hs.17936 |
-9.2 |
Below |
2.2 |
| 7 |
206090_s_at |
disrupted in schizophrenia 1 |
DISC1 |
Chr:1q42.1 |
NM_018662 |
Hs.26985 |
8.7 |
Above |
1.7 |
| 8 |
206940_s_at |
POU domain, class 4, transcription
factor 1 |
POU4F1 |
Chr:13q21.1-q22 |
NM_006237 |
Hs.458303 |
8.7 |
Above |
16.6 |
| 9 |
34210_at |
CDW52 antigen (CAMPATH-1 antigen) |
CDW52 |
Chr:1p36 |
N90866 |
Hs.276770 |
8.7 |
Above |
3.5 |
| 10 |
211341_at |
POU domain, class 4, transcription
factor 1 |
POU4F1 |
Chr:13q21.1-q22 |
L20433 |
Hs.458303 |
8.5 |
Above |
31.1 |
| 11 |
218825_at |
EGF-like-domain, multiple 7 |
EGFL7 |
Chr:9q34.3 |
NM_016215 |
Hs.91481 |
8.4 |
Above |
3.0 |
| 12 |
204661_at |
CDW52 antigen (CAMPATH-1 antigen) |
CDW52 |
Chr:1p36 |
NM_001803 |
Hs.276770 |
8.3 |
Above |
3.4 |
| 13 |
208891_at |
dual specificity phosphatase 6 |
DUSP6 |
Chr:12q22-q23 |
BC003143 |
Hs.298654 |
8.2 |
Above |
2.5 |
| 14 |
208893_s_at |
dual specificity phosphatase 6 |
DUSP6 |
Chr:12q22-q23 |
BC005047 |
Hs.298654 |
8.2 |
Above |
2.8 |
| 15 |
218858_at |
hypothetical protein FLJ12428 |
FLJ12428 |
Chr:8q24.12 |
NM_022783 |
Hs.87729 |
8.1 |
Above |
2.4 |
| 16 |
204811_s_at |
calcium channel, voltage-dependent,
alpha 2/delta subunit 2 |
CACNA2D2 |
Chr:3p21.3 |
NM_006030 |
Hs.389415 |
7.9 |
Above |
5.3 |
| 17 |
204020_at |
purine-rich element binding protein
A |
PURA |
Chr:5q31 |
BF739943 |
Hs.29117 |
-7.8 |
Below |
2.5 |
| 18 |
218899_s_at |
brain and acute leukemia, cytoplasmic |
BAALC |
Chr:8q22.3 |
NM_024812 |
Hs.169395 |
7.6 |
Above |
3.8 |
| 19 |
211685_s_at |
neurocalcin delta |
NCALD |
Chr:8q22-q23 |
AF251061 |
Hs.90063 |
7.6 |
Above |
2.3 |
| 20 |
216831_s_at |
core-binding factor, runt domain,
alpha subunit 2; translocated to, 1; cyclin
D-related |
CBFA2T1 |
Chr:8q22 |
AF018283 |
Hs.90858 |
7.6 |
Above |
21.4 |
| 21 |
208892_s_at |
dual specificity phosphatase 6 |
DUSP6 |
Chr:12q22-q23 |
BC003143 |
Hs.298654 |
7.5 |
Above |
2.2 |
| 22 |
212496_s_at |
KIAA0876 protein |
KIAA0876 |
Chr:19p13.3 |
BE256900 |
Hs.301011 |
7.5 |
Above |
2.2 |
| 23 |
220560_at |
chromosome 11 open reading frame
21 |
C11orf21 |
Chr:11p15.5 |
NM_014144 |
Hs.272100 |
-7.4 |
Below |
3.0 |
| 24 |
221760_at |
mannosidase, alpha, class 1A, member
1 |
MAN1A1 |
Chr:6q22 |
BG287153 |
Hs.255149 |
7.4 |
Above |
3.7 |
| 25 |
209543_s_at |
CD34 antigen |
CD34 |
Chr:1q32 |
M81104 |
Hs.374990 |
7.4 |
Above |
3.2 |
| 26 |
212097_at |
caveolin 1, caveolae protein, 22kDa |
CAV1 |
Chr:7q31.1 |
AU147399 |
Hs.74034 |
7.2 |
Above |
9.1 |
| 27 |
206855_s_at |
hyaluronoglucosaminidase 2 |
HYAL2 |
Chr:3p21.3 |
NM_003773 |
Hs.76873 |
7.1 |
Above |
1.6 |
| 28 |
210010_s_at |
solute carrier family 25 (mitochondrial
carrier; citrate transporter), member 1 |
SLC25A1 |
Chr:22q11.21 |
U25147 |
Hs.111024 |
7.1 |
Above |
1.9 |
| 29 |
219686_at |
gene for serine/threonine protein
kinase |
HSA250839 |
Chr:4p16.2 |
NM_018401 |
Hs.58241 |
7.0 |
Above |
4.2 |
| 30 |
205173_x_at |
CD58 antigen, (lymphocyte function-associated
antigen 3) |
CD58 |
Chr:1p13 |
NM_001779 |
Hs.75626 |
7.0 |
Above |
2.3 |
| 31 |
208978_at |
cysteine-rich protein 2 |
CRIP2 |
Chr:14q32.3 |
U36190 |
Hs.70327 |
7.0 |
Above |
4.2 |
| 32 |
219478_at |
WAP four-disulfide core domain
1 |
WFDC1 |
Chr:16q24.3 |
NM_021197 |
Hs.36688 |
6.8 |
Above |
2.8 |
| 33 |
216356_x_at |
BAI1-associated protein 3 |
BAIAP3 |
Chr:16p13.3 |
AB018277 |
Hs.458427 |
6.8 |
Above |
2.8 |
| 34 |
212136_at |
ATPase, Ca++ transporting, plasma
membrane 4 |
ATP2B4 |
Chr:1q25-q32 |
AW517686 |
Hs.343522 |
-6.8 |
Below |
1.7 |
| 35 |
208116_s_at |
mannosidase, alpha, class 1A, member
1 |
MAN1A1 |
Chr:6q22 |
NM_005907 |
Hs.255149 |
6.8 |
Above |
3.0 |
| 36 |
336_at |
--- |
--- |
--- |
D38081 |
--- |
6.7 |
Above |
1.9 |
| 37 |
203865_s_at |
adenosine deaminase, RNA-specific,
B1 (RED1 homolog rat) |
ADARB1 |
Chr:21q22.3 |
NM_015833 |
Hs.148822 |
-6.7 |
Below |
5.3 |
| 38 |
204021_s_at |
purine-rich element binding protein
A |
PURA |
Chr:5q31 |
NM_005859 |
Hs.29117 |
-6.7 |
Below |
2.9 |
| 39 |
219271_at |
UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase
T10 |
GalNac-T10 |
Chr:2p23.2 |
NM_024572 |
Hs.15830 |
6.7 |
Above |
2.7 |
| 40 |
200989_at |
hypoxia-inducible factor 1, alpha
subunit (basic helix-loop-helix transcription
factor) |
HIF1A |
Chr:14q21-q24 |
NM_001530 |
Hs.412416 |
6.6 |
Above |
1.7 |
| 41 |
201968_s_at |
phosphoglucomutase 1 |
PGM1 |
Chr:1p31 |
NM_002633 |
Hs.1869 |
-6.6 |
Below |
1.8 |
| 42 |
204285_s_at |
phorbol-12-myristate-13-acetate-induced
protein 1 |
PMAIP1 |
Chr:18q21.32 |
AI857639 |
Hs.96 |
6.6 |
Above |
2.3 |
| 43 |
211744_s_at |
CD58 antigen, (lymphocyte function-associated
antigen 3) |
CD58 |
Chr:1p13 |
BC005930 |
Hs.75626 |
6.6 |
Above |
2.4 |
| 44 |
221581_s_at |
Williams-Beuren syndrome chromosome
region 5 |
WBSCR5 |
Chr:7q11.23 |
AF257135 |
Hs.56607 |
-6.5 |
Below |
3.5 |
| 45 |
201137_s_at |
major histocompatibility complex,
class II, DP beta 1 |
HLA-DPB1 |
Chr:6p21.3 |
NM_002121 |
Hs.368409 |
6.5 |
Above |
2.3 |
| 46 |
206631_at |
prostaglandin E receptor 2 (subtype
EP2), 53kDa |
PTGER2 |
Chr:14q22 |
NM_000956 |
Hs.2090 |
6.4 |
Above |
1.9 |
| 47 |
204794_at |
dual specificity phosphatase 2 |
DUSP2 |
Chr:2q11 |
NM_004418 |
Hs.1183 |
6.4 |
Above |
2.8 |
| 48 |
221865_at |
DKFZp547P234 protein |
DKFZp547P234 |
Chr:9q33.1 |
BF969986 |
Hs.170226 |
6.4 |
Above |
1.7 |
| 49 |
204086_at |
preferentially expressed antigen
in melanoma |
PRAME |
Chr:22q11.22 |
NM_006115 |
Hs.30743 |
6.3 |
Above |
3.3 |
| 50 |
212135_s_at |
ATPase, Ca++ transporting, plasma
membrane 4 |
ATP2B4 |
Chr:1q25-q32 |
AW517686 |
Hs.343522 |
-6.3 |
Below |
1.8 |
| 51 |
213194_at |
hypothetical protein FLJ10539 |
FLJ10539 |
Chr:3p14.2 |
BF059159 |
Hs.301198 |
6.3 |
Above |
7.8 |
| 52 |
218352_at |
regulator of chromosome condensation
(RCC1) and BTB (POZ) domain containing protein
1 |
RCBTB1 |
Chr:13q14 |
NM_018191 |
Hs.58452 |
6.3 |
Above |
2.1 |
| 53 |
200665_s_at |
secreted protein, acidic, cysteine-rich
(osteonectin) |
SPARC |
Chr:5q31.3-q32 |
NM_003118 |
Hs.111779 |
6.3 |
Above |
2.8 |
| 54 |
206726_at |
prostaglandin D2 synthase, hematopoietic |
PGDS |
Chr:4q22.3 |
NM_014485 |
Hs.128433 |
6.3 |
Above |
3.5 |
| 55 |
207375_s_at |
interleukin 15 receptor, alpha |
IL15RA |
Chr:10p15-p14 |
NM_002189 |
Hs.12503 |
6.2 |
Above |
2.1 |
| 56 |
204990_s_at |
integrin, beta 4 |
ITGB4 |
Chr:17q11-qter |
NM_000213 |
Hs.85266 |
6.2 |
Above |
3.0 |
| 57 |
212099_at |
ras homolog gene family, member
B |
ARHB |
Chr:2pter-p12 |
AI263909 |
Hs.406064 |
6.2 |
Above |
2.6 |
| 58 |
212895_s_at |
active BCR-related gene |
ABR |
Chr:17p13.3 |
AL527773 |
Hs.434004 |
-6.2 |
Below |
2.1 |
| 59 |
211991_s_at |
major histocompatibility complex,
class II, DP alpha 1 |
HLA-DPA1 |
Chr:6p21.3 |
M27487 |
Hs.914 |
6.2 |
Above |
2.2 |
| 60 |
210744_s_at |
interleukin 5 receptor, alpha |
IL5RA |
Chr:3p26-p24 |
M75914 |
Hs.68876 |
6.2 |
Above |
6.8 |
| 61 |
205101_at |
MHC class II transactivator |
MHC2TA |
Chr:16p13 |
NM_000246 |
Hs.126714 |
6.1 |
Above |
2.4 |
| 62 |
203773_x_at |
biliverdin reductase A |
BLVRA |
Chr:7p14-cen |
NM_000712 |
Hs.435726 |
6.1 |
Above |
1.8 |
| 63 |
216942_s_at |
CD58 antigen, (lymphocyte function-associated
antigen 3) |
CD58 |
Chr:1p13 |
D28586 |
Hs.75626 |
6.1 |
Above |
2.4 |
| 64 |
201497_x_at |
myosin, heavy polypeptide 11, smooth
muscle |
MYH11 |
Chr:16p13.13-p13.12 |
NM_022844 |
Hs.78344 |
6.1 |
Above |
4.9 |
| 65 |
218742_at |
protein related to Narf |
HPRN |
Chr:16p13.3 |
NM_022493 |
Hs.22158 |
6.1 |
Above |
2.1 |
| 66 |
211031_s_at |
cytoplasmic linker 2 |
CYLN2 |
Chr:7q11.23 |
BC006259 |
Hs.104717 |
-6.1 |
Below |
2.6 |
| 67 |
201700_at |
cyclin D3 |
CCND3 |
Chr:6p21 |
NM_001760 |
Hs.83173 |
-6.0 |
Below |
1.9 |
| 68 |
203741_s_at |
adenylate cyclase 7 |
ADCY7 |
Chr:16q12-q13 |
NM_001114 |
Hs.172199 |
-6.0 |
Below |
2.3 |
| 69 |
203932_at |
major histocompatibility complex,
class II, DM beta |
HLA-DMB |
Chr:6p21.3 |
NM_002118 |
Hs.1162 |
6.0 |
Above |
2.1 |
| 70 |
218205_s_at |
MAP kinase-interacting serine/threonine
kinase 2 |
MKNK2 |
Chr:19p13.3 |
NM_017572 |
Hs.512094 |
6.0 |
Above |
1.5 |
| 71 |
217989_at |
retinal short-chain dehydrogenase/reductase
2 |
RETSDR2 |
Chr:4q22.1 |
NM_016245 |
Hs.282984 |
6.0 |
Above |
1.4 |
| 72 |
211729_x_at |
biliverdin reductase A |
BLVRA |
Chr:7p14-cen |
BC005902 |
Hs.435726 |
6.0 |
Above |
1.7 |
| 73 |
202664_at |
Wiskott-Aldrich syndrome protein
interacting protein |
WASPIP |
Chr:2q31.2 |
AW058622 |
Hs.401414 |
6.0 |
Above |
1.4 |
| 74 |
207134_x_at |
tryptase beta 2 |
TPSB2 |
Chr:16p13.3 |
NM_024164 |
Hs.405479 |
6.0 |
Above |
3.8 |
| 75 |
217795_s_at |
hypothetical protein MGC3222 |
MGC3222 |
Chr:3p25.1 |
W74580 |
Hs.130330 |
6.0 |
Above |
1.3 |
| 76 |
205760_s_at |
8-oxoguanine DNA glycosylase |
OGG1 |
Chr:3p26.2 |
NM_016821 |
Hs.380271 |
-5.9 |
Below |
2.3 |
| 77 |
219890_at |
C-type (calcium dependent, carbohydrate-recognition
domain) lectin, superfamily member 5 |
CLECSF5 |
Chr:7q33 |
NM_013252 |
Hs.126355 |
5.9 |
Above |
2.5 |
| 78 |
212495_at |
KIAA0876 protein |
KIAA0876 |
Chr:19p13.3 |
BE256900 |
Hs.301011 |
5.9 |
Above |
1.8 |
| 79 |
208178_x_at |
triple functional domain (PTPRF
interacting) |
TRIO |
Chr:5p15.1-p14 |
NM_007118 |
Hs.367689 |
5.9 |
Above |
2.3 |
| 80 |
210613_s_at |
synaptogyrin 1 |
SYNGR1 |
Chr:22q13.1 |
BC000731 |
Hs.414343 |
5.9 |
Above |
1.7 |
| 81 |
33304_at |
interferon stimulated gene 20kDa |
ISG20 |
Chr:15q26 |
U88964 |
Hs.105434 |
5.9 |
Above |
2.0 |
| 82 |
218613_at |
hypothetical protein DKFZp761K1423 |
DKFZp761K1423 |
Chr:8p22 |
NM_018422 |
Hs.236438 |
5.9 |
Above |
2.7 |
| 83 |
221012_s_at |
tripartite motif-containing 8 |
TRIM8 |
Chr:10q24.3 |
NM_030912 |
Hs.54580 |
-5.8 |
Below |
1.8 |
| 84 |
203355_s_at |
ADP-ribosylation factor guanine
nucleotide factor 6 |
EFA6R |
Chr:8pter-p23.3 |
NM_015310 |
Hs.408177 |
5.8 |
Above |
3.5 |
| 85 |
205683_x_at |
tryptase beta 2 |
TPSB2 |
Chr:16p13.3 |
NM_003294 |
Hs.405479 |
5.8 |
Above |
3.5 |
| 86 |
221218_s_at |
thiamin pyrophosphokinase 1 |
TPK1 |
Chr:7q34-q35 |
NM_022445 |
Hs.127548 |
5.8 |
Above |
1.6 |
| 87 |
205330_at |
meningioma (disrupted in balanced
translocation) 1 |
MN1 |
Chr:22q11 |
NM_002430 |
Hs.268515 |
5.8 |
Above |
2.8 |
| 88 |
202255_s_at |
signal-induced proliferation-associated
1-like 1 |
KIAA0440 |
Chr:14q24.1 |
NM_015556 |
Hs.172180 |
5.8 |
Above |
2.6 |
| 89 |
220668_s_at |
DNA (cytosine-5-)-methyltransferase
3 beta |
DNMT3B |
Chr:20q11.2 |
NM_006892 |
Hs.251673 |
-5.8 |
Below |
2.5 |
| 90 |
204929_s_at |
vesicle-associated membrane protein
5 (myobrevin) |
VAMP5 |
Chr:2p11.2 |
NM_006634 |
Hs.74669 |
5.7 |
Above |
2.0 |
| 91 |
221497_x_at |
egl nine homolog 1 (C. elegans) |
EGLN1 |
Chr:1q42.1 |
BC005369 |
Hs.130946 |
5.7 |
Above |
1.8 |
| 92 |
218749_s_at |
hypothetical protein FLJ22233 |
FLJ22233 |
Chr:12q24.21 |
NM_024959 |
Hs.286194 |
-5.7 |
Below |
1.8 |
| 93 |
216832_at |
core-binding factor, runt domain,
alpha subunit 2; translocated to, 1; cyclin
D-related |
CBFA2T1 |
Chr:8q22 |
AF018283 |
Hs.90858 |
5.7 |
Above |
1.8 |
| 94 |
202370_s_at |
core-binding factor, beta subunit |
CBFB |
Chr:16q22.1 |
NM_001755 |
Hs.179881 |
-5.7 |
Below |
1.5 |
| 95 |
212706_at |
DNA directed RNA polymerase II
polypeptide J-related gene |
POLR2J2 |
Chr:7q11.22 |
AB011110 |
Hs.406505 |
5.7 |
Above |
1.7 |
| 96 |
207081_s_at |
phosphatidylinositol 4-kinase,
catalytic, alpha polypeptide |
PIK4CA |
Chr:22q11.21 |
NM_002650 |
Hs.334874 |
-5.7 |
Below |
1.4 |
| 97 |
217080_s_at |
homer homolog 2 (Drosophila) |
HOMER2 |
Chr:15q24.3 |
Y19026 |
Hs.93564 |
5.7 |
Above |
1.9 |
| 98 |
203733_at |
dexamethasone-induced transcript |
DEXI |
Chr:16p13.2 |
NM_014015 |
Hs.157925 |
-5.7 |
Below |
4.3 |
| 99 |
201473_at |
jun B proto-oncogene |
JUNB |
Chr:19p13.2 |
NM_002229 |
Hs.400124 |
5.7 |
Above |
2.0 |
| 100 |
217023_x_at |
--- |
--- |
--- |
AF099143 |
--- |
5.7 |
Above |
3.7 |